---
title: "Revelation Biosciences (REVB.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/REVB.US/norm.md"
symbol: "REVB.US"
name: "Revelation Biosciences"
parent: "https://longbridge.com/zh-CN/quote/REVB.US.md"
datetime: "2026-03-10T01:31:09.546Z"
locales:
  - [en](https://longbridge.com/en/quote/REVB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/REVB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/REVB.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/REVB.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/REVB.US/norm.md)


# Revelation Biosciences (REVB.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -1.65 | -7.07 | -28.04 | -25.34 | -59.77 |
| ROE | -101.13% | -252.34% | -671.13% | -216.21% | -187.02% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -2.51M | -4.68M | -5.63M | -2.05M | -1.73M |
| 营业利润 | -2.57M | -1.94M | -2.46M | -2.09M | -1.75M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 11.58M | 12.86M | 5.40M | 3.97M | 6.62M |
| 权益乘数 | 1.31 | 1.17 | 1.41 | 1.38 | 1.41 |
| 每股净资产 | 5.59 | 12.27 | 9.97 | 35.87 | 108.19 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 10.76M | 12.71M | 5.17M | 3.70M | 6.50M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 740355.00 | 23919.00 | 35170.00 | 42390.00 | 56332.00 |
| 净债务 | -10.01M | -12.71M | -5.17M | -3.70M | -6.50M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -1.97M | -1.59M | -1.92M | -2.79M | -3.75M |
| 投资现金流 | - | - | - | - | 17689.00 |
| 融资现金流 | -41166.00 | 9.12M | 3.39M | - | 3.69M |
| 自由现金流 | -1.04M | -859427.00 | -1.01M | -2.06M | -3.10M |
| 现金流充裕率 | - | - | - | - | 21186.28% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | 17689.00 |